Max Oscherwitz

Max Oscherwitz

Auto-generated profile, based on publicly available information

Max Oscherwitz

Heersink School of Medicine, University of Alabama, Birmingham, AL 35294, USA

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 September 2023 in Genes
Verified
Journal Article
Open access
PDF file
MOMax Oscherwitz
Max Oscherwitz
VJVictoria Jiminez
Victoria Jiminez
HTHanna Terhaar
Hanna Terhaar
NYNabiha Yusuf
Nabiha Yusuf
Morbidity and mortality from skin cancer continue to rise domestically and globally, and melanoma and non-melanoma skin cancers are a topic of interest in the dermatology and oncology communities. In this review, we summarize the stimulator of interferon genes (STING) pathway, its specific role in the pathogenesis of DNA damage and skin cancer, and STING-specific therapies that may fight both melanoma and non-melanoma skin (NMSC) cancers. Furthermore, we discuss specific portions of the STING pathway that may be used in addition to previously used therapies to provide a synergistic effect in future oncology treatments and discuss the limitations of current STING-based therapies.